Regular Article
Diabetic hypoglycaemia

https://doi.org/10.1053/beem.1999.0020Get rights and content

Abstract

Hypoglycaemia is a major factor preventing insulin-treated patients from achieving normoglycaemia. This reflects the inadequacy of current insulin treatment, which causes high insulin concentrations in the post-absorptive period. Physiological defences to hypoglycaemia include autonomic activation, which limits the fall in glucose level and causes symptoms, alerting patients to an impending episode. Many patients develop defective responses and hypoglycaemia unawareness after longstanding disease or with tight glycaemic control and are then prone to severe attacks. This may be the result of repeated hypoglycaemic episodes, which by altering cerebral glucose uptake, disturb the mechanisms that activate the central response to hypoglycaemia. Preventing further hypoglycaemia can partially reverse these defects and restore symptomatic awareness. Clinical hypoglycaemia has also been implicated in the ‘dead in bed’ syndrome and in chronic cognitive impairment. The problem of hypoglycaemia will eventually be solved by better insulin delivery and non-invasive glucose meters, but until then, more focused education may have a more substantial impact.

References (87)

  • NS Schwartz et al.

    The glycemic thresholds for the activation of glucose counterregulation are higher than the threshold for symptoms

    Journal of Clinical Investigation

    (1987)
  • RL Brunelle et al.

    Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes

    Diabetes Care

    (1998)
  • RB Tattersall

    Frequency and causes of hypoglycaemia

  • Diabetes Care

    (1995)
  • S Pramming et al.

    Symptomatic hypoglycaemia in 411 type 1 diabetic patients

    Diabetic Medicine

    (1991)
  • Lancet

    (1998)
  • SR Heller

    Hypoglycaemia and type 2 diabetes: insulin therapy

  • I Mühlhauser et al.

    Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes—a prospective population based study

    Diabetologia

    (1998)
  • S Bott et al.

    Intensified insulin therapy and the risk of severe hypoglycaemia

    Diabetologia

    (1997)
  • S Pampanelli et al.

    Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia

    Diabetologia

    (1996)
  • SR Heller et al.

    Hypoinsulinemia is not critical to glucose recovery from hypoglycemia in humans

    American Journal of Physiology

    (1991)
  • RA Rizza et al.

    Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia

    Journal of Clinical Investigation

    (1979)
  • PE Cryer

    Hypoglycemia: the limiting factor in the management of IDDM

    Diabetes

    (1994)
  • IJ Deary et al.

    Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis

    Diabetologia

    (1993)
  • RJ McCrimmon et al.

    Symptoms of hypoglycemia in children with IDDM

    Diabetes Care

    (1995)
  • AJ Jaap et al.

    Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin

    Diabetic Medicine

    (1998)
  • A Mitrakou et al.

    Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction

    American Journal of Physiology

    (1991)
  • GB Bolli et al.

    Abnormal glucose counterregulation in IDDM. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion

    Diabetes

    (1983)
  • JE Gerich et al.

    Lack of glucagon response to hypoglycaemia in diabetes; evidence for an intrinsic pancreatic alpha cell defect

    Science

    (1973)
  • GJ Taborsky et al.

    Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes

    Diabetes

    (1998)
  • BR Hirsch et al.

    Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific

    Diabetes

    (1987)
  • JE Gerich et al.

    Counterregulatory failure

  • NH White et al.

    Identificaiton of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy

    New England Journal of Medicine

    (1983)
  • A Fritsche et al.

    Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects

    Diabetes Care

    (1998)
  • DA Hepburn et al.

    Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy

    Diabetic Medicine

    (1990)
  • I Mühlhauser et al.

    Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus

    Diabetes Care

    (1985)
  • AE Gold et al.

    Frequency of severe hypoglycemia in patients with type I (insulin dependent) diabetes with impaired awareness of hypoglycemia

    Diabetes Care

    (1994)
  • RD Hoeldtke et al.

    Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy

    Annals of Internal Medicine

    (1982)
  • R EJ Ryder et al.

    Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy

    British Medical Journal

    (1990)
  • DA Hepburn et al.

    Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy

    Diabetic Medicine

    (1993)
  • P Bottini et al.

    Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycaemia in IDDM

    Diabetes

    (1997)
  • SA Amiel et al.

    Effect of intensive insulin therapy on glycemic threshold for counterregulatory hormone release

    Diabetes

    (1988)
  • A Goldfien et al.

    Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycaemia in man

    Journal of Clinical Endocrinology and Metabolism

    (1961)
  • Cited by (24)

    • Insulin therapy and hypoglycemia

      2012, Endocrinology and Metabolism Clinics of North America
      Citation Excerpt :

      Spyer and colleagues55 reported that counterregulation occurs at higher glucose levels in well-controlled (HgbA1c 7.4%) type 2 DM than in nondiabetic individuals. Heller54 found that when type 1 and type 2 DM patients are matched for insulin therapy and glycemic control there is not a significant difference in hypoglycemia frequency. In a study comparing those with and without hypoglycemia unawareness and type 2 DM, Ohno and colleagues63 found indirect evidence to suggest autonomic neuropathy in those with hypoglycemia unawareness.

    • Etiopathogenesis of cataract: An appraisal

      2014, Indian Journal of Ophthalmology
    View all citing articles on Scopus
    View full text